Creo Medical Group (LON:CREO) Shares Pass Above Fifty Day Moving Average – What’s Next?

Creo Medical Group PLC (LON:CREO)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 12.27 and traded as high as GBX 12.50. Creo Medical Group shares last traded at GBX 11.75, with a volume of 367,287 shares changing hands.

Analysts Set New Price Targets

Separately, Shore Capital Group restated a “house stock” rating on shares of Creo Medical Group in a research note on Thursday, April 16th.

Creo Medical Group Stock Down 3.1%

The stock has a 50 day moving average of GBX 12.27 and a 200-day moving average of GBX 12.15. The firm has a market capitalization of £48.46 million, a P/E ratio of -11.75 and a beta of 1.50. The company has a debt-to-equity ratio of 6.90, a quick ratio of 2.19 and a current ratio of 5.28.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.